Explore practical diet and nutrition guidance for diabetes, including healthy foods, meal planning, portion control and everyday eating habits for better management.
The global pipeline for type 2 diabetes now features more than 80 treatment candidates from over 75 companies, highlighting rapid innovation driven by new approvals, cardiovascular focus, and diverse delivery platforms amidst rising obesity and ageing populations. DelveInsight says the…
While higher dietary magnesium is associated with improved insulin resistance, experts warn that supplement claims are often exaggerated, emphasising the importance of diet and lifestyle for metabolic health. The viral promise is neat enough to fit on social media: take…
The inaugural Trebinje Diabetes Forum emphasised that early diagnosis and personalised care are vital in preventing organ damage from diabetes, as healthcare professionals and patients came together for free tests, expert talks, and the latest management strategies. The first Trebinje…
A food engineer explains the distinctions between high- and lower-intensity sweeteners, highlighting how their unique properties influence health and sugar reduction strategies, amid mixed research findings. Sweeteners are often marketed as simple swaps for sugar, but food engineer Montse Meléndez…
An increasing wave of product liability lawsuits has emerged across the US, accusing makers of popular GLP-1 drugs like Ozempic and Wegovy of causing sudden, permanent vision loss due to NAION. While some countries update warning labels, US courts grapple…
A new study reveals that over a million Americans are receiving GLP-1 medicines without approved indications, spotlighting rising off-label prescribing, potential disparities, and safety questions amid a rapidly expanding market. A study published in the journal Obesity suggests that more…
A UCLA-led study reveals that insurance programmes like Medicaid and Medicare’s Low-Income Subsidy help improve medication adherence among Black and Hispanic Medicare Advantage enrollees, yet significant disparities remain, highlighting the need for targeted systemic and community-based solutions. A study led…
Research in Malawi shows that standard BMI screenings may overlook significant cases of abdominal obesity among adults with type 2 diabetes, potentially leading to missed opportunities for targeted intervention as waist-to-height ratio proves to be a more accurate predictor of…
Revvity launches CE-IVDR-certified GSP T1D 3plex kit to identify at-risk children before symptoms appear, leveraging existing platforms amidst market optimism and investor caution. Revvity has launched its GSP T1D 3plex kit, a diagnostic system aimed at helping identify children at…
Viral claims that poha is inherently harmful for people with diabetes have been challenged by experts, emphasising portion size and preparation as key factors in its health impact. Viral claims that poha is automatically bad for people with diabetes have…
Hikma Pharmaceuticals enters the booming GLP-1 market with the launch of Glucentra, the first generic semaglutide available in Saudi Arabia, signalling a strategic shift towards innovation and pipeline growth. Hikma Pharmaceuticals has moved into the fast-growing market for GLP-1 medicines…
Biolinq’s needle-free Shine wearable has received FDA approval for over-the-counter use, marking a significant step in consumer glucose monitoring and challenging traditional medical device regulations. Biolinq Incorporated said on Thursday that the US Food and Drug Administration has cleared its…
